Rhode Island House Bill 7118: Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provides the list to the attorney general to obtain reasons for the cost increases.

Rhode Island · 2026 session

What it does

BUSINESSES AND PROFESSIONS -- PHARMACEUTICAL COST TRANSPARENCY - Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provides the list to the attorney general to obtain reasons for the cost increases.

Latest action

Committee recommended measure be held for further study (2026-03-24)

See how H 7118 affects you on CapitolKey

Browse more bills · CapitolKey home